

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.83%
-9.70%
+2.50%
+3.16%
-8.72%
HLNE
Hamilton Lane Incorporate
$119.32
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
Risk Analysis

Investors losing their confidence
Chart
$140.9 (-15.32%)
$154.54 (-22.79%)
$149.51 (-20.19%)
$192.63 (-38.06%)
HLNE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

HLNE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
HLNE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HLNE Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayHLNE Earnings
The TTM reflects 12-month period, providing review of HLNE financial performance.
The company financial health has moderately improved over the past year
Financial Score
VCTR
63.58
+0.61%
OWL
16.64
+2.05%
JHG
41.63
+1.22%
BEN
22.84
+0.73%
ARES
150.13
+1.15%
What is HLNE current stock price?
What are HLNE stock strengths?
What risks are associated with HLNE stock?
When is HLNE next earnings report?
What is HLNE market cap and volume?
What is HLNE's current Stock IQ?
Should I buy HLNE stock right now?
Is HLNE a Strong Buy right now?
What does a 'Strong Buy' rating mean for HLNE?
What does a 'Strong Sell' rating mean for HLNE?
What factors influence HLNE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.83%
-9.70%
+2.50%
+3.16%
-8.72%
HLNE
Hamilton Lane Incorporate
Current Price
$119.32
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
Risk Analysis

Investors losing their confidence
Linked to HLNE
VCTR
63.58
+0.61%
OWL
16.64
+2.05%
JHG
41.63
+1.22%
BEN
22.84
+0.73%
ARES
150.13
+1.15%
Chart
$140.9 (-15.32%)
$154.54 (-22.79%)
$149.51 (-20.19%)
$192.63 (-38.06%)
HLNE Analysts Opinion
HLNE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
HLNE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HLNE Street view is extremely bullish and have positive views on the near-term outlook
HLNE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
HLNE Earnings
The TTM data reflects the most recent 12-month period, providing overview of HLNE financial performance.
HLNE Financial Health
The company financial health has moderately improved over the past year
Financial Score
HLNE Latest Analysis
Oppenheimer Upgrades Hamilton Lane (HLNE). Fintel reports that on October 14 2025 Oppenheimer upgraded their outlook for Hamilton Lane (NasdaqGS:HLNE) from Perform to Outperform. Analyst Price Forecast Suggests 35.10% Upside
Wed Oct 15, 2025
Why Hamilton Lanes Correction Isnt Over Yet. Hamilton Lane Inc. (NASDAQ:) is currently in Phase 11 of its 18-phase Adhishthana cycle and is traversing through the descent leg of its Adhishthana Himalayan Formation. While the stock has already corrected from its highs the Adhishthana framework suggests there may still be some downside left before stability returns.Under the Adhishthana Principles stocks typically form a Cakra structure between Phases 4 and 8 a channel-like formation that usually
Tue Oct 14, 2025
Hamilton Lane Buys $12 Million Stake in Pagaya as AI Fintech Stock Surges. Key PointsHamilton Lane Advisors acquired 407435 shares of Pagaya Technologies for an estimated $12.1 million in the third quarter.
Tue Oct 7, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HLNE Stock trends
HLNE Stock performance
HLNE Stock analysis
HLNE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.